Please login to the form below

Not currently logged in

AZ appoints Alexion’s Aradhana Sarin as chief financial officer

Sarin will become AZ's new chief financial officer upon closing of the company’s acquisition of Alexion Pharmaceuticals

AstraZeneca (AZ) has appointed Aradhana Sarin (pictured above) as its new chief financial officer and an executive director upon closing of the company’s acquisition of Alexion Pharmaceuticals, expected in the third quarter of 2021.

Currently, Sarin serves as executive vice president and chief financial officer of Alexion, a role she progressed to after joining the company in 2017 as chief business and strategy officer.

She has over 20 years of experience gained from operating roles at Alexion and advisory roles at global financial institutions, AZ said in a statement.

Prior to joining Alexion, she served as managing director, healthcare corporate & investment banking at Citi Global Banking. In this role, she advised clients working in the life sciences and biopharmaceutical industries.

She also previously held the role of managing director, healthcare investment banking at UBS and worked at JP Morgan in the M&A Advisory and Healthcare groups.

Before embarking on her banking career, Sarin trained as a medical doctor in India and spent two years practising medicine in India and Africa.

At AZ, she will succeed current chief financial officer Marc Dunoyer, who will step down from the role and retire from the company’s board upon closing of the acquisition. Dunoyer will then go on to become chief executive officer of the Alexion unit and chief strategy officer of AZ.

Meanwhile, Sarin will relocate from the US to be based in the UK, and will report to AZ’s chief executive officer Pascal Soriot.

“I’d like to pay tribute to Marc for his tremendous achievements since he joined our company, and thank him personally for his outstanding support these past years,” said Soriot.

"I’m looking forward to working with him in his new role as CEO, Alexion, the Rare Disease Unit of AstraZeneca, and to his continued strategic input to AstraZeneca’s success.  I’m delighted Aradhana has agreed to become AstraZeneca’s next CFO and I look forward to working with her as the company embarks on the next stage of its journey,” he added.

Article by
Lucy Parsons

7th June 2021

From: Research, Marketing



COVID-19 Updates and Daily News

Featured jobs


Add my company

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....